跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nutlin
首页
药物
Nutlin
Nutlin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PEPTIDE FTTFTVT FOR USE IN TREATING FIBROSIS
申请人: UNIV TEXAS
优先权: 2013
CN
EP
US
10 件公开
TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENT
申请人: KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIV MUENCHEN
优先权: 2019
CN
EP
US
WO
4 件公开
BENZIMIDAZOLE HETEROATOM-CONTAINING SPIRO COMPOUND AND MEDICINAL USE THEREOF
申请人: UNIV CHANGZHI
优先权: 2023
CN
US
3 件公开
SENOLYTIC DRUG SCREENING METHOD AND SENOLYTIC DRUG
申请人: UNIV KYOTO
优先权: 2021
CN
US
2 件公开
NOVEL COMPOUNDS CAPABLE OF INDUCING OSTEOGENIC DIFFERENTIATION
申请人: UNIV AJOU IND ACADEMIC COOP FOUND
优先权: 2023
EP
WO
2 件公开
Individual and combination of mdivi-1 and nutlin-3 for topical or intravitreal ophthalmic use
申请人: CHAN IAN H
优先权: 2010
US
2 件公开
Stereoselective methods, catalysts and intermediates for the synthesis of ()-Nutlin-3 and related compounds
申请人: JOHNSTON JEFFREY N
优先权: 2011
US
2 件公开
Method for treating ocular cancer
申请人: DYER MICHAEL A
优先权: 2011
US
2 件公开
Nutlin-3A for treatment of proliferative vitreoretinopathy
申请人: THE SCHEPENS EYE RES INST INC
优先权: 2013
US
2 件公开
Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use
申请人: UNITY BIOTECHNOLOGY INC
优先权: 2017
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈